🔗 Share this article

A shadow market for unapproved slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on new investigations.

Experimental Treatment Acquiring Traction Via Social Media

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing effects. Followers are urged to contact these profiles privately for source information, while also receiving promotional offers.

Thriving Trade on Messaging Platforms

Additionally, a robust market exists on Telegram, where communities with numerous of participants share comparison images, injection guides and claims of next-day British shipping. Vendors promote the substance there before redirecting customers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an investigational injectable developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help individuals lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Medical Experts Voice Worries

Nevertheless, physicians and chemists have cautions that the distribution of what remains an unapproved drug in the UK is a cause for concern and could lead to individuals administering products of uncertain source.

Several experts stated the popularity for the experimental drug could be linked to the rising cost of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Implementation

Marketing retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved medication that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still violate medicines, advertising, and customer laws, potentially leading to penalties, prosecution or prison.

Service Reaction and Material Removal

Based on the social media company, the platform has removed problematic material and prohibited related keywords and search suggestions. The company stated it was dedicated to keeping the platform safe and allocating resources in strengthening compliance measures.

Online Trading Operations

Investigations also found groups with up to 9,000 participants selling the experimental drug using Telegram's built-in discovery tool, which functions like a public directory. Entering “retatrutide” instantly displays channels with numerous of members, populated with images of slimming results, positive testimonials and detailed instructions for preparing or administering at home.

After minutes of joining one group, a vendor shared WhatsApp details, where the majority of purchases occur. The vendor provided an instruction manual and promised delivery within two days. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another shared a image of a alleged testing documentation. Not one asked about weight, medical conditions or previous experience.

Item Information and Costs

Inside these communities, messages show black plastic parcels with postal service labels, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at home with sterile water, or ready-to-use injectors typically priced at 160 pounds for 20mg. When asked how long a injector should be used, sellers give contradictory responses varying between a several days to “depends on your body”.

Service Moderation and Safety Actions

A representative for the messaging service stated it actively moderated dangerous content on its service including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are administering materials they cannot confirm. Although the science behind this drug is valid, these digital versions may not contain what they claim,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of an online medical service linked the surge in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With costs rising, individuals are using online platforms. But counterfeit treatments are highly risky. You cannot know what’s contained or whether the environment they were produced in was clean,” she said.

Her staff has previously seen patients harmed by personal administration from unverified suppliers. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your health,” said the doctor. “These materials could be contaminated or improperly measured.”

Manufacturer Statement

A spokesperson from the pharmaceutical company said the substance was in third stage research studies and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this point no one can market [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company investigational substance not yet approved … may expose users to possibly significant health risks”.